NCT05582239

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,400 (estimated)
• Sponsor: ANRS, Emerging Infectious Diseases · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is a prospective, multicentric, observational test negative design study on adults hospitalized for Severe Acute Respiratory Infection (SARI), regardless of their vaccination status.

Detailed description

Participation to the study will be systematically proposed to all patients hospitalized fitting inclusion criteria. Patient's screening will be done in emergency department or hospital department with direct admission. Medical investigators explain the objectives of the studies, procedure and propose the patient to participate in the study. Socio-demographic data, clinical and virological data will be collected in an electronic clinical research form. A follow-up at 1 and 3 months after hospitalization discharge will be scheduled to evaluate health status. The remainder of respiratory samples that have been performed for care will be used for further testing depending on epidemiological situation and will be stored at -80°C.

Conditions

• Severe Acute Respiratory Infection (SARI)
• Influenza
• COVID-19

Timeline

• Start date: 2023-01-20
• Primary completion: 2026-01-20
• Completion: 2026-01-20
• First posted: 2022-10-17
• Last updated: 2023-05-17

Locations

8 sites across 1 country: France